Vanguard Personalized Indexing Management, LLC Cytom X Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 28,966 shares of CTMX stock, worth $68,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,966
Previous 17,708
63.58%
Holding current value
$68,939
Previous $11,000
490.91%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTMX
# of Institutions
64Shares Held
44.1MCall Options Held
8.9KPut Options Held
47.9K-
Tang Capital Management LLC San Diego, CA6.72MShares$16 Million0.28% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$12.4 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.12MShares$12.2 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$9.35 Million0.9% of portfolio
-
Acadian Asset Management LLC Boston, MA3.23MShares$7.7 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $157M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...